clopidogrel sandoz
acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:* patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.
oxaliplatino sandoz 5 mg/ml concentrado para solución para perfusión i.v.
sandoz gmbh, kundl - oxaliplatino - oxaliplatino....50.00 mg. / oxaliplatino....100.00 mg.
capecitabina sandoz 150 mg tabletas recubiertas
sandoz gmbh, kundl - capecitabina - capecitabina....150 mg
glimepirid sandoz tablets
sandoz gmbh, kundl, austria - glimepiride - tablets - 2mg
glimepirid sandoz tablets 4
sandoz gmbh, kundl, austria - glimepiride - tablets - 4
capecitabine sandoz 150mg film-coated tablet
sandoz gmbh kundl biochemiestrasse 10 a-6250 - capecitabine - film-coated tablet - 150mg - capecitabine
capecitabine sandoz 500mg film-coated tablet
sandoz gmbh kundl biochemiestrasse 10 a-6250 - capecitabine - film-coated tablet - 500mg - capecitabine
amoxicillin sandoz
sandoz gmbh - amoxicillin trihydrate - capsules hard - 500 milligram
amoxicillin sandoz 500 milligram capsules hard
sandoz gmbh - amoxicillin trihydrate - capsules hard - 500 milligram
fingolimod sandoz fingolimod (as hydrochloride) 0.5 mg capsule blister pack
sandoz pty ltd - fingolimod hydrochloride, quantity: 0.56 mg (equivalent: fingolimod, qty 0.5 mg) - capsule, hard - excipient ingredients: mannitol; iron oxide yellow; magnesium stearate; gelatin; titanium dioxide - fingolimod sandoz is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.